Skip to main content
Clinical Trials/NCT06130592
NCT06130592
Not yet recruiting
Not Applicable

Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal Ultrasound Screening of Congenital Multiple Arthrogryposis

University Hospital, Grenoble0 sites230 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arthrogryposis Multiplex Congenita (AMC)
Sponsor
University Hospital, Grenoble
Enrollment
230
Primary Endpoint
Rate of achievement (success) of all four sections at the extremities
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The objective of the study is to evaluate the performance of muscle ultrasound sections on antenatal ultrasound between 21-24 amenorrhea weeks for the screening of muscle atrophy, in a sample of low-risk and high-risk pregnancies of congenital multiple arthrogryposis

Detailed Description

Frequent rare diseases (100-200 births in France / year), congenital multiple arthrogryposis include a set of pathologies characterized by the limitation of joint movements at least two joint levels.Their functional prognosis and muscle atrophy are often severe after birth. Routine ultrasound call signs are either non-specific or insensitive and difficult to detect due to time constraints. Antenatal ultrasound screening is not very effective for these pathologies, which are often particularly serious. The main criterion will be the success rate of realization of all four ultrasound sections at the extremities (deltoide, biceps, quadriceps, triceps) and measurements of the distances "skin - muscle fascia" and "muscular fascia - periosteum" between 21-24 amenorrhea weeks

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
February 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
University Hospital, Grenoble
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Any pregnant woman consulting in one of the two obstetric gynecology departments in connection with the CPDPN (Multidisciplinary Prenatal Diagnostic Centers) of the University hospitals of Lyon or Grenoble.
  • Mono-embryonic pregnancy.
  • Gestational ages retained on the first dating ultrasound or the 1st trimester ultrasound between 21-24 amenorrhea weeks.
  • For women at "high risk": diagnosis during ultrasound of the 1st, 2nd, or 3rd trimesters, of an abnormality of position / deformation of one or more joints, and / or an abnormality of fetal movements on screening ultrasound or interrogation (population group at "high risk of AMC").
  • Regulatory criteria: adults, affiliated to a social security scheme, having signed a consent

Exclusion Criteria

  • Multiple pregnancies, and / or non-progressive .
  • Obese women (BMI \> 30 in early pregnancy)
  • Subject in a period of exclusion from another study
  • Subject under administrative or judicial supervision
  • Subject who cannot be contacted in case of emergency

Outcomes

Primary Outcomes

Rate of achievement (success) of all four sections at the extremities

Time Frame: 72 hours +/- 24 hours

Rate of achievement (success) of all four sections at the extremities for measurements (in mm) of the distances "skin - muscular aponeurosis" and "muscular aponeurosis- periosteum" between 21-24 amenorrhea weeks

Secondary Outcomes

  • Rate of achievement (success) of each four sections(72 hours +/- 24 hours)
  • Comparison of the completion rates of all cuts during ultrasounds between high- and low-risk patients(72 hours +/- 24 hours)
  • Concordance of measures (CCI coefficient) will be evaluated in intra-observer and inter-observer respectively(72 hours +/- 24 hours)
  • Collect the raisons for the failure of achievement of all sections(72 hours +/- 24 hours)
  • Duration of realization of the ultrasound sections(72 hours +/- 24 hours)

Similar Trials